Last updated 2026-07-20
- Raised $18M Series A led by Ilex Medical, Feb 2026
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Ronen Kalmanson is the co-founder and Chairman of Starget Pharma, an Israeli biotech company founded in 2019. Starget Pharma develops Smart Targeted Radioligands (STRs) for precision oncology therapies, combining therapeutic drugs with radioactive isotopes for targeted cancer diagnosis and treatment. The company's platform uses AI to engineer radioactive molecules that identify and bind to unique receptors in cancer cells, aiming to reduce side effects and deliver more focused treatment. Starget Pharma has raised $38 million to date and is preparing for advanced clinical trials for various cancers, including sarcoma, skin cancer, neuroendocrine tumors, breast cancer, and prostate cancer.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Business Software1
Q&A
- What is Ronen Kalmanson's primary investment focus by sector?
- Ronen Kalmanson has shown a focus on the Business Software sector, with one investment in this area.
- What is Ronen Kalmanson's typical investment stage?
- Ronen Kalmanson has participated in Pre-Seed funding rounds.
- Can you name a notable company in Ronen Kalmanson's portfolio?
- A notable company in Ronen Kalmanson's portfolio is Fly Money, which operates in the Business Software sector.
- What is the business model of Fly Money, a company in Ronen Kalmanson's portfolio?
- Fly Money, a portfolio company of Ronen Kalmanson, operates with B2B2C and B2C business models.
- What is the total amount raised by Fly Money, a company backed by Ronen Kalmanson?
- Fly Money, a company in Ronen Kalmanson's portfolio, has raised $1.01M.
- When was Fly Money, a portfolio company of Ronen Kalmanson, founded?
- Fly Money, a company backed by Ronen Kalmanson, was founded in 2015.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2019 |
|---|